Unlocking Shortage of Alpha Emitting Isotope With Lead-212 to Tap TAT Full Potential
Time: 11:25 am
day: Day 1 - Track B (AM)
Details:
• Interest of lead-212 for the development of TRP
• Providing a reliable supply chain for 212Pb-based therapies
• Developing a robust pipeline of 212Pb-based therapies for patients’ benefit
